Marinus Pharmaceuticals sells a drug to reduce seizures in people with a rare genetic disorder. Recently, a study showed the ...
Bank of America Securities analyst Victoria Petrova has maintained their bullish stance on HLN stock, giving a Buy rating on November 4.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback